More

    WHO recommends two new drugs to treat patients with COVID-19

    HealthCOVID-19WHO recommends two new drugs to treat patients with...
    - Advertisment -

    WHO recommends two new drugs to treat patients with COVID-19

    A guideline development group of international experts have made the recommendation based on new evidence from seven trials involving over 4,000 patients with non-severe, severe, and critical COVID-19 infection.

    The World Health Organisation has strongly recommended the use of the drug baricitinib (a drug used to treat rheumatoid arthritis) for patients with severe or critical COVID-19 in combination with corticosteroids. This recommendation by a WHO Guideline Development Group of international experts in has been reported in The BMJ today.

    Their strong recommendation is based on moderate certainty evidence that it improves survival and reduces the need for ventilation, with no observed increase in adverse effects.

    The WHO experts note that baricitinib has similar effects to other arthritis drugs called interleukin-6 (IL-6) inhibitors so, when both are available, they suggest choosing one based on cost, availability, and clinician experience. It is not recommended to use both drugs at the same time.

    - Advertisement -

    However, the experts advise against the use of two other JAK inhibitors (ruxolitinib and tofacitinib) for patients with severe or critical COVID-19 because low certainty evidence from small trials failed to show benefit and suggests a possible increase in serious side effects with tofacitinib.

    In the same guideline update, WHO also makes a conditional recommendation for the use of the monoclonal antibody sotrovimab in patients with non-severe COVID-19, but only in those at highest risk of hospitalisation, reflecting trivial benefits in those at lower risk.

    A similar recommendation has been made by WHO for another monoclonal antibody drug (casirivimab-imdevimab). The experts also note that there were insufficient data to recommend one monoclonal antibody treatment over another – and they acknowledge that their effectiveness against new variants like omicron is still uncertain.

    As such, they say guidelines for monoclonal antibodies will be updated when additional data become available.

    Living guidelines

    Today’s recommendations are based on new evidence from seven trials involving over 4,000 patients with non-severe, severe, and critical COVID-19 infection.

    They are part of a living guideline, developed by the World Health Organization with the methodological support of MAGIC Evidence Ecosystem Foundation, to provide trustworthy guidance on the management of COVID-19 and help doctors make better decisions with their patients.

    Living guidelines are useful in fast moving research areas like COVID-19 because they allow researchers to update previously vetted and peer reviewed evidence summaries as new information becomes available.

    To make their recommendations, the panel considered a combination of evidence assessing relative benefits and harms, values and preferences, and feasibility issues.

    Today’s guidance adds to previous recommendations for the use of interleukin-6 receptor blockers and systemic corticosteroids for patients with severe or critical COVID-19; conditional recommendations for the use of casirivimab-imdevimab (another monoclonal antibody treatment) in selected patients; and against the use of convalescent plasma, ivermectin and hydroxychloroquine in patients with covid-19 regardless of disease severity.

     

    Image: Illustration of the Novel Coronavirus, created at the Centers for Disease Control and Prevention (CDC).

    - Advertisement -

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Latest news

    Governance Reforms to Include Digital Empowerment of Citizens

    Union Minister Dr. Jitendra Singh says “Continuing the reforms and revamping training structures and methodologies to optimize the performance...

    Ministry of Education Issues Advisory to ensure RTE Entitlements to Children with Special Needs

    The aim is to ensure the NEP 2020 objective of providing access to quality education for all, including children...

    Nepalese Women Unionists Demand Recognising Community Health Work as Work

    In a first, two community health workers from Nepal are participating in the ILO's ongoing annual meeting Geneva, Switzerland....

    Climate Change Widening Asia’s Education Gap

    Extreme heat and flooding are forcing kids to miss classes across Asia, amid concerns that climate change could be...
    - Advertisement -

    FAO Report: Global fisheries and Aquaculture Production Reaches New Record High

    Aquaculture growth indicates its capacity to further contribute to meeting the rising global demand for aquatic foods, but future...

    Global Temperature Likely to Exceed 1.5°C Above Pre-Industrial Level Temporarily in Next Five Years

    The chance of at least one of the next five years exceeding 1.5°C has risen steadily since 2015, when...

    Must read

    Governance Reforms to Include Digital Empowerment of Citizens

    Union Minister Dr. Jitendra Singh says “Continuing the reforms...
    - Advertisement -

    More from the sectionRELATED
    Recommended to you